Brown Capital Management LLC Glaukos Corp Transaction History

Brown Capital Management LLC

  • $3.34 Billion
  • Q2 2025

A detailed history of Brown Capital Management LLC transactions in Glaukos Corp stock. As of the latest transaction made, Brown Capital Management LLC holds 1,139,119 shares of GKOS stock, worth $102 Million. This represents 3.53% of its overall portfolio holdings.

Number of Shares
1,139,119
Previous 1,192,589 4.48%
Holding current value
$102 Million
Previous $117 Million 0.24%
% of portfolio
3.53%
Previous 3.63%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$82.27 - $103.29 $4.4 Million - $5.52 Million
-53,470 Reduced 4.48%
1,139,119 $118 Million
Q1 2025

May 15, 2025
SELL
$96.6 - $161.22 $15 Million - $25 Million
-155,268 Reduced 11.52%
1,192,589 $117 Million
Q4 2024

Feb 14, 2025
SELL
$126.42 - $152.67 $36.2 Million - $43.8 Million
-286,734 Reduced 17.54%
1,347,857 $202 Million
Q3 2024

Nov 12, 2024
SELL
$113.62 - $135.39 $29.9 Million - $35.7 Million
-263,365 Reduced 13.88%
1,634,591 $213 Million
Q2 2024

Aug 12, 2024
SELL
$89.48 - $118.35 $21 Million - $27.8 Million
-234,891 Reduced 11.01%
1,897,956 $225 Million
Q1 2024

May 15, 2024
SELL
$76.4 - $96.33 $43.2 Million - $54.4 Million
-564,947 Reduced 20.94%
2,132,847 $201 Million
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $5.32 Million - $7.61 Million
89,420 Added 3.43%
2,697,794 $214 Million
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $1.99 Million - $2.27 Million
-28,720 Reduced 1.09%
2,608,374 $196 Million
Q2 2023

Aug 14, 2023
SELL
$45.44 - $71.21 $12.2 Million - $19.1 Million
-267,564 Reduced 9.21%
2,637,094 $188 Million
Q1 2023

May 15, 2023
BUY
$43.88 - $52.48 $8.42 Million - $10.1 Million
191,849 Added 7.07%
2,904,658 $146 Million
Q4 2022

Feb 14, 2023
SELL
$40.82 - $57.75 $5.99 Million - $8.48 Million
-146,845 Reduced 5.14%
2,712,809 $118 Million
Q3 2022

Nov 14, 2022
BUY
$46.84 - $58.49 $9.82 Million - $12.3 Million
209,589 Added 7.91%
2,859,654 $152 Million
Q2 2022

Aug 15, 2022
SELL
$34.86 - $63.77 $7.65 Million - $14 Million
-219,351 Reduced 7.64%
2,650,065 $120 Million
Q1 2022

May 16, 2022
SELL
$44.33 - $57.82 $6.76 Million - $8.81 Million
-152,380 Reduced 5.04%
2,869,416 $166 Million
Q4 2021

Feb 14, 2022
SELL
$40.27 - $56.99 $7.81 Million - $11.1 Million
-194,062 Reduced 6.03%
3,021,796 $134 Million
Q3 2021

Nov 15, 2021
SELL
$47.43 - $84.23 $124 Million - $220 Million
-2,611,212 Reduced 44.81%
3,215,858 $155 Million
Q2 2021

Aug 16, 2021
SELL
$73.06 - $97.7 $38.6 Million - $51.6 Million
-527,779 Reduced 8.31%
5,827,070 $494 Million
Q1 2021

May 14, 2021
SELL
$70.43 - $97.42 $10.9 Million - $15 Million
-154,425 Reduced 2.37%
6,354,849 $533 Million
Q4 2020

Feb 16, 2021
SELL
$48.9 - $75.26 $3.01 Million - $4.63 Million
-61,487 Reduced 0.94%
6,509,274 $490 Million
Q3 2020

Nov 13, 2020
BUY
$37.23 - $50.97 $70.3 Million - $96.2 Million
1,888,286 Added 40.33%
6,570,761 $325 Million
Q2 2020

Aug 07, 2020
BUY
$28.78 - $46.83 $2.23 Million - $3.63 Million
77,524 Added 1.68%
4,682,475 $180 Million
Q1 2020

May 08, 2020
BUY
$25.53 - $70.14 $995,287 - $2.73 Million
38,985 Added 0.85%
4,604,951 $142 Million
Q4 2019

Feb 14, 2020
BUY
$54.18 - $65.64 $39,117 - $47,392
722 Added 0.02%
4,565,966 $249 Million
Q3 2019

Nov 13, 2019
BUY
$58.58 - $83.91 $114 Million - $163 Million
1,946,782 Added 74.35%
4,565,244 $285 Million
Q2 2019

Aug 13, 2019
BUY
$63.59 - $78.71 $9.6 Million - $11.9 Million
150,931 Added 6.12%
2,618,462 $197 Million
Q1 2019

May 15, 2019
BUY
$50.75 - $80.54 $7.78 Million - $12.3 Million
153,276 Added 6.62%
2,467,531 $193 Million
Q4 2018

Feb 14, 2019
BUY
$52.18 - $67.93 $121 Million - $157 Million
2,314,255 New
2,314,255 $130 Million

Others Institutions Holding GKOS

# of Institutions
333
Shares Held
54M
Call Options Held
259K
Put Options Held
481K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.25B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Brown Capital Management LLC Portfolio

Follow Brown Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email